メンタルヘルスとセラピー向けチャットボットの世界市場-2024～2031年

概要

世界のメンタルヘルスとセラピー向けチャットボット市場は、2023年に11億米ドルに達し、2031年には17億6,000万米ドルに達すると予測され、予測期間2024-2031年のCAGRは6.2%で成長すると予測されます。

セラピーチャットボットは、メンタルヘルスチャットボットとも呼ばれ、個人の心の健康管理を支援するために設計された高度な会話AIシステムです。これらのチャットボットは、自然言語処理（NLP）や機械学習などの技術を活用し、有意義な会話でユーザーを巻き込み、メンタルヘルスの状態を評価し、パーソナライズされた対処戦略やリソースを提供します。モバイルアプリケーション、ウェブサイト、メッセージングアプリなど、さまざまなプラットフォームからアクセスできます。

メンタルヘルスとセラピー向けチャットボットは、人間のような会話をシミュレートし、ユーザーに心理的なサポートやリソースを提供するように設計されたAI主導のツールです。これらのチャットボットは、認知行動療法（CBT）などのエビデンスに基づいた治療技術を取り入れ、個人のメンタルヘルス管理を支援します。即座の応答とサポートを提供することで、特に従来のメンタルヘルスサービスが制限されていたり、スティグマ化されていたりする地域において、助けを求める人々にとって利用しやすい最初のコンタクトポイントとしての役割を果たします。このような要因が、世界のメンタルヘルスとセラピー向けチャットボット市場拡大の原動力となっています。

市場力学：

促進要因と阻害要因

利用しやすいメンタルヘルスサービスに対する需要の増加

アクセシブルなメンタルヘルスサービスに対する需要の高まりが、世界のメンタルヘルスとセラピー向けチャットボット市場の成長を大きく後押ししており、市場予測期間中もその傾向が続くと予測されています。

世界保健機関（WHO）の報告によると、パンデミックは世界のメンタルヘルスに深刻な影響を及ぼし、その結果、不安とうつ病の割合は世界で25％増加しました。この時期に経験した孤立、病気への恐怖、経済的不安定、悲しみは、既存のメンタルヘルス問題を悪化させ、新たな問題を引き起こしました。

従来のメンタルヘルスサービスは、予約のための長い待ち時間、専門家の限られた利用可能性、地理的制約など、しばしば大きな障害に遭遇します。このような課題により、助けを求めることを躊躇してしまう人も少なくないです。チャットボットは、いつでも即座にサポートとリソースを提供することで、実行可能な代替手段を提供します。

例えば、2023年1月には、Limbic Inc.が開発したAIを搭載したメンタルヘルス評価ツールであるLimbic Accessの有効性を強調する重要な研究が発表されました。この調査は、イングランドの28のNHS Talking Therapiesサービスにおける129,400人の患者を対象としたもので、AIを使用することで、特に不利な立場にあるグループのメンタルヘルス支援へのアクセスが大幅に向上することが実証されました。この調査では、非バイナリティの人々のメンタルヘルス支援へのアクセスが179％増加したことが明らかになった。また、少数民族グループでのアクセスも29％増加しました。これは、リンビック・アクセスが、歴史的にメンタルヘルス・サービスへのアクセスに障壁に直面してきた層に効果的にアプローチしたことを示しています。

同様に、2021年10月にランセット誌に掲載された論文によると、パンデミックは世界のメンタルヘルスに多大な影響を及ぼし、世界中で約7,600万件の不安症と5,300万件のうつ病を引き起こしました。このメンタルヘルス障害の驚異的な増加は、パンデミックの社会的、経済的、健康関連の混乱に関連するいくつかの要因に起因しています。これらすべての要因が、世界のメンタルヘルスとセラピー向けチャットボット市場に需要をもたらしています。

さらに、業界の主要企業は、これらの世界のメンタルヘルスとセラピー向けチャットボット市場の成長を促進するような製品の発売や投資を行います。例えば、Limbic Inc.は2023年1月、心理療法の効率と効果を高めるために設計された革新的なメンタルヘルス評価ツール「Limbic Access」を発表しました。Limbic AccessはAIを搭載したチャットボットで、メンタルヘルス支援を求める個人に対して、安全かつ臨床的に効果的で、リスク管理されたサポートを提供することに注力しています。

また、2023年10月、BeMeHealthはその成長と拡大努力を支援する新たな戦略的投資家を発表しました。この投資により、BeMeHealthは、メンタルヘルスケアを改善することを目的とした、より高度な技術やサービスを取り入れ、提供するサービスを強化することが可能になると思われます。資本の流入により、BeMeHealthは新機能を開発したり、サービスが行き届いていない市場に手を伸ばしたりすることができ、それによってメンタルヘルスケア提供への影響力を高めることができるかもしれないです。これらすべての要因が、世界のメンタルヘルスとセラピー向けチャットボット市場に需要をもたらしています。

さらに、デジタルヘルスプラットフォームとの統合は、世界のメンタルヘルスとセラピー向けチャットボット市場の拡大に貢献しています。

プライバシーとデータセキュリティへの懸念

プライバシーとデータセキュリティの懸念は、世界のメンタルヘルスとセラピー向けチャットボット市場の成長を妨げます。

メンタルヘルスチャットボットは、メンタルヘルス状態、感情状態、個人履歴の詳細など、センシティブな個人情報の開示をユーザーに求めることが多いです。このようなデータはプライベートなものであるため、ユーザーはその情報が漏洩したり悪用されたりすることを恐れる可能性があります。このような情報を共有することに伴う脆弱性は、プライバシーをめぐる利害を増大させる。

評判の高いチャットボット・プロバイダーが強力なセキュリティ対策を実施しているにもかかわらず、データ漏洩のリスクは依然として大きな懸念事項となっています。サイバーセキュリティの脅威は広がっており、機密データはハッキングや不正アクセスによって漏洩する可能性があります。このような侵害は、個人情報が公開された場合の精神的苦痛や潜在的な汚名など、ユーザーにとって深刻な影響につながる可能性があります。

2024年のA Vinove Companyのデータによると、AIチャットボットを通じて機密性の高いメンタルヘルス情報を扱う場合、プライバシーに関する重大な懸念が生じると述べています。すべてのやり取りが暗号化され、安全に保存されるとともに、GDPRやHIPAAなどの規制に準拠することが不可欠です。チャットボットはサポートを提供する上で非常に効果的ですが、人間の複雑な感情を完全に把握するのに苦労することがよくあります。この限界は、より複雑な状況において、誤解や不十分な応答をもたらす可能性があります。

多くのメンタルヘルスチャットボットは、ユーザーデータがどのように収集、保存、利用されるかを伝えていないです。ユーザーは、自分のデータが広告主や医療保険会社などの第三者と共有されているかどうかを知らない可能性があります。このような透明性の欠如は、自分の情報がどのように扱われるのか、またそれが守秘義務に対する期待に沿うものなのかを個人が心配する可能性があるため、これらのプラットフォームに対する信頼を損なう可能性があります。

このように、上記の要因は世界のメンタルヘルスとセラピー向けチャットボット市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • メンタルヘルスサービスへのアクセスに対する需要の増加
  • 抑制要因
    • プライバシーとデータセキュリティに関する懸念
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 技術別

• 自然言語処理（NLP）
• 機械学習（ML）
• その他

第7章 コンポーネント別

• ソフトウェア
• サービス

第8章 用途別

• 症状の評価
• 治療サポート
• 危機管理
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Woebot Health
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Wysa Ltd
• Youper Inc.
• X2ai Inc.
• Quartet Health
• Headspace Health
• Marigold Health
• BioBeats
• Lyra Health, Inc.
• Limbic（LIST NOT EXHAUSTIVE）

第12章 付録

Overview

The global chatbots for mental health and therapy market reached US$ 1.10 billion in 2023 and is expected to reach US$ 1.76 billion by 2031, growing at a CAGR of 6.2% during the forecast period 2024-2031.

Therapy chatbots, also referred to as mental health chatbots, are advanced conversational AI systems designed to assist individuals in managing their mental well-being. These chatbots leverage technologies such as natural language processing (NLP) and machine learning to engage users in meaningful conversations, assess their mental health status, and provide personalized coping strategies or resources. They can be accessed through various platforms, including mobile applications, websites, and messaging apps.

Chatbots for mental health and therapy are AI-driven tools designed to simulate human-like conversations, providing psychological support and resources to users. These chatbots incorporate evidence-based therapeutic techniques, such as Cognitive Behavioral Therapy (CBT), to assist individuals in managing their mental health. By offering immediate responses and support, they serve as accessible first points of contact for those seeking help, especially in areas where traditional mental health services may be limited or stigmatized. These factors have driven the global chatbots for mental health and therapy market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Accessible Mental Health Services

The increasing demand for accessible mental health services is significantly driving the growth of the global chatbots for mental health and therapy market and is expected to drive throughout the market forecast period.

The pandemic has profoundly affected global mental health, resulting in a 25% increase in anxiety and depression rates worldwide, as reported by the World Health Organization (WHO). The isolation, fear of illness, financial instability, and grief experienced during this time have exacerbated existing mental health issues and introduced new ones.

Traditional mental health services often encounter significant obstacles, such as long wait times for appointments, limited availability of professionals, and geographic constraints. Many individuals are discouraged from seeking help due to these challenges. Chatbots offer a viable alternative by providing immediate support and resources at any time.

Furthermore, key players in the industry research studies that would drive the global chatbots for mental health and therapy market growth.For instnace, in January 2023, a significant study was published that highlighted the effectiveness of Limbic Access, an AI-powered mental health assessment tool developed by Limbic Inc. This research involved 129,400 patients across 28 NHS Talking Therapies services in England and demonstrated that the use of AI can significantly enhance access to mental health support, particularly for underrepresented groups. The study found a remarkable 179% increase in access to mental health support among non-binary individuals. There was also a 29% increase in access among ethnic minority groups. This indicates that Limbic Access effectively reached demographics that have historically faced barriers to accessing mental health services.

Similarly, according to a publication in The Lancet in October 2021, the pandemic had a profound impact on global mental health, triggering approximately 76 million cases of anxiety and 53 million cases of depression worldwide. This staggering increase in mental health disorders can be attributed to several factors associated with the pandemic's social, economic, and health-related disruptions. All these factors demand the global chatbots for mental health and therapy market.

Additionally, key players in the industry product launches and investments that would drive these global chatbots for mental health and therapy market growth. For instance, in January 2023, Limbic Inc. launched Limbic Access, an innovative mental health assessment tool designed to enhance the efficiency and effectiveness of psychological therapies. Limbic Access is an AI-powered chatbot that focuses on providing secure, clinically effective, and risk-managed support for individuals seeking mental health assistance.

Also, in October 2023, BeMeHealth announced a new strategic investor that will support its growth and expansion efforts. The investment will enable BeMeHealth to enhance its offerings, likely incorporating more advanced technologies or services aimed at improving mental health care. The influx of capital may allow BeMeHealth to develop new features or expand its reach into underserved markets, thereby increasing its impact on mental health care delivery. All these factors demand the global chatbots for mental health and therapy market.

Moreover, the Integration with Digital Health Platforms contributes to the global chatbots for mental health and therapy market expansion.

Privacy and Data Security Concerns

The privacy and data security concerns will hinder the growth of the global chatbots for mental health and therapy market.

Mental health chatbots often require users to disclose sensitive personal information, such as details about their mental health conditions, emotional states, and personal histories. Given the private nature of this data, users may fear that it could be exposed or misused. The vulnerability associated with sharing such information increases the stakes surrounding privacy.

Despite the implementation of strong security measures by reputable chatbot providers, the risk of data breaches remains a major concern. Cybersecurity threats are widespread, and sensitive data could potentially be compromised through hacking or unauthorized access. Such breaches can lead to severe repercussions for users, including emotional distress and potential stigma if their private information is made public.

According to the A Vinove Company data in 2024, stated that when dealing with sensitive mental health information through AI chatbots, significant privacy concerns arise. It is essential to ensure that all interactions are encrypted and securely stored, as well as compliant with regulations such as GDPR and HIPAA. Although chatbots can be very effective in offering support, they often struggle to grasp the full complexity of human emotions. This limitation can result in misunderstandings or inadequate responses in more complicated situations.

Many mental health chatbots do not communicate how user data is collected, stored, or utilized. Users may be unaware if their data is shared with third parties, such as advertisers or health insurance companies. This lack of transparency can undermine trust in these platforms, as individuals may worry about how their information is handled and whether it aligns with their expectations for confidentiality.

Thus, the above factors could be limiting the global chatbots for mental health and therapy market's potential growth.

Segment Analysis

The global chatbots for mental health and therapy market is segmented based on technology, component, application, and region.

Technology:

The natural language processing (NLP) segment is expected to dominate the global chatbots for mental health and therapy market share

The natural language processing (NLP) segment holds a major portion of the global chatbots for mental health and therapy market share and is expected to continue to hold a significant portion of the global chatbots for mental health and therapy market share during the forecast period.

Natural Language Processing (NLP) equips chatbots with the ability to analyze and interpret the complexities of human language, allowing for more natural and empathetic conversations. This capability is vital for fostering a supportive environment where users feel heard and validated. By incorporating sentiment analysis, chatbots can assess the emotional tone of user interactions. This functionality enables them to respond appropriately, offering empathy and customized support based on the user's emotional state, which is crucial in mental health scenarios.

According to the Springer Nature research publication in October 2023, neuropsychiatric disorders impose a significant societal burden, but their treatment is complicated by the absence of objective outcomes and fidelity metrics. Artificial intelligence technologies, particularly Natural Language Processing (NLP), have emerged as valuable tools for analyzing mental health interventions (MHI) by examining the conversations that comprise them.

Natural Language Processing (NLP) enhances a chatbot's ability to maintain contextual awareness throughout interactions. By recalling previous conversations and referencing them, chatbots can offer more personalized and relevant assistance over time, thereby improving user engagement and satisfaction. The application of NLP allows chatbots to tailor responses according to individual user preferences and needs. This personalization may involve adjusting the communication style or providing specific mental health resources that resonate with the user's situation.

The integration of machine learning models with NLP enables chatbots to continually refine their responses based on user interactions and feedback. This ongoing learning process enhances the chatbot's adaptability to changing language patterns and individual user requirements. These factors have solidified the segment's position in the global chatbots for mental health and therapy market.

Geographical Analysis

North America is expected to hold a significant position in the global chatbots for mental health and therapy market share

North America holds a substantial position in the global chatbots for mental health and therapy market and is expected to hold most of the market share.

The region has a considerable number of individuals suffering from mental health issues such as depression, anxiety, and stress-related disorders. This widespread prevalence creates a robust demand for accessible mental health services, driving the adoption of innovative solutions like chatbots.

North America features a well-established healthcare infrastructure that supports the integration of digital health technologies. The availability of advanced technological resources facilitates the effective deployment of AI-driven solutions, including chatbots, making them more efficient and widely accessible.

There is a strong focus on leveraging technology to enhance mental health care delivery in North America. Companies are investing significantly in developing sophisticated chatbots that utilize advanced Natural Language Processing (NLP) and machine learning techniques to improve user interactions and therapeutic outcomes.

Furthermore, in this region, a major number of key players' presence, government initiatives & regulatory support, and product launches would propel these global chatbots for mental health and therapy market growth. For instance, in November 2024, Jimini Health, a digital health startup, launched its services with $8 million in pre-seed funding aimed at transforming mental healthcare through a unique clinician-led therapy model augmented by responsible artificial intelligence (AI). The funding round saw participation from notable investors including Zetta Venture Partners, LionBird, PsyMed, BoxGroup, Arkitekt Ventures, and SCB.

Also, in March 2023, Botpress, launched the industry's first visual builder tool that enables users to create advanced chatbots capable of executing complex workflows on top of ChatGPT in just a matter of minutes in Canada. This innovation is designed to democratize chatbot creation, making it accessible to a wider range of users, including those without extensive programming knowledge. Users can develop customized personal assistants, educational bots, coding assistants, social service hotlines, mental health support bots, smart email responders, and life coaching guides.

Thus, the above factors are consolidating the region's position as a dominant force in the global chatbots for mental health and therapy market.

Asia Pacific is growing at the fastest pace in the global chatbots for mental health and therapy market share

Asia Pacific holds the fastest pace in the global chatbots for mental health and therapy market and is expected to hold most of the market share.

In Asia-Pacific region is experiencing an increase in mental health issues, including anxiety, depression, and stress-related disorders. This growing prevalence creates a strong demand for accessible mental health services, which chatbots can effectively provide.

According to the National Center for Biotechnology Information (NCBI) research publication in July 2023, in India, mental health disorders are highly prevalent, affecting a significant portion of the population. Epidemiological studies indicate that the prevalence rates for psychiatric disorders range from 9.5 to 370 per 1,000 individuals. This wide range reflects the diverse challenges faced by individuals in the country. The high prevalence of mental health disorders underscores the urgent need for effective interventions and support systems to enhance the mental well-being of the population. Commonly observed conditions include depression, anxiety disorders, bipolar disorder, schizophrenia, and substance use disorders.

Rapid urbanization in countries such as China and India is leading to lifestyle changes that often contribute to heightened stress and mental health challenges. As urban populations expand, there is a corresponding rise in the demand for convenient mental health solutions like chatbots. The proliferation of smartphones and internet connectivity in the Asia-Pacific region facilitates the use of digital health solutions. Chatbots, accessible via mobile devices, are becoming increasingly popular among individuals seeking immediate mental health support.

Furthermore, in this region, key player's initiatives, such as partnerships & collaborations, and product launches would drive the global healthcare chatbots market growth. For instance, in June 2023, the Osmania Technology Business Incubator (OTBI) in collaboration with Findhope, took place at Osmania University. This event provided a unique platform for students to engage in discussions centered around mental well-being and contribute innovative ideas aimed at enhancing Findhope's AI WhatsApp chatbot.

Also, in April 2024, Wysa, launched a Hindi version of its conversational AI therapy app, aiming to enhance the accessibility of quality mental health services in underserved communities across India, particularly in Tier II and III cities. This initiative addresses significant barriers to mental health care in regions where access to traditional therapy is limited.

Similarly, in July 2023, Jammu and Kashmir (J&K) launched India's first Tele-MANAS chatbot, designed to provide immediate support for individuals in mental distress. This initiative aims to enhance mental health services in the region by ensuring round-the-clock access to health counselors, clinical psychologists, and consultants.

Also, in April 2024, the Chinese University of Hong Kong (CUHK) launched an AI chatbot aimed at providing mental health support to the youth in Hong Kong, particularly in response to the increasing demand for mental health services and the growing complexity of cases among students. This initiative is part of the Jockey Club TourHeart+ project, which has been enhanced by a donation from the Hong Kong Jockey Club.

Thus, the above factors are consolidating the region's position as the fastest-growing force in the global chatbots for mental health and therapy market.

Competitive Landscape

The major global players in the chatbots for mental health and therapy market include Woebot Health, Wysa Ltd, Youper Inc., X2ai Inc., Quartet Health, Headspace Health, Marigold Health, BioBeats, Lyra Health, Inc., and Limbic among others.

Key Developments

• In November 2024, Rogers Behavioral Health announced a partnership with Limbic Inc. to implement an AI chatbot, Limbic Access, aimed at transforming its patient intake process. This initiative marks a significant shift from the traditional phone-based intake system to a more modern, AI-driven approach that enhances accessibility and efficiency in mental health care.
• In November 2024, HealthSci.AI launched an innovative suite of health-focused and biotech-driven chatbots designed to empower users with personalized guidance and support across a wide range of health and biotechnology topics. This initiative aims to provide an accessible pathway for users to proactively manage their health and navigate the complexities of biotechnology with confidence.
• In June 2024, Sonia is a newly launched AI chatbot designed to provide a convenient and accessible alternative to traditional therapy. Developed by a startup of the same name, Sonia utilizes multiple generative AI models to analyze user interactions during therapy sessions conducted through the app, allowing it to respond appropriately to users' needs. Sonia is designed to address a wide range of mental health challenges, including depression, stress, anxiety, relationship issues, and sleep disturbances. This broad focus allows it to cater to diverse user needs.
• In April 2024, Fortis Healthcare launched Adayu Mindfulness, an AI-powered chatbot designed to provide mental health support for individuals facing psychological challenges. This innovative application serves as a digital-first aid kit for mental health, particularly targeting those who may be hesitant to seek professional help due to societal stigma surrounding mental health issues.
• In January 2024, the GPT Store launched by OpenAI, is a groundbreaking platform that allows users to buy and sell custom AI chatbots, including those designed for mental health support. This store has generated significant interest due to its diverse offerings, which range from highly effective and serious applications to more unconventional or "wacko" chatbots.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global chatbots for mental health and therapy market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Technology
• 3.2. Snippet by Component
• 3.3. Snippet by Application
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand for Accessible Mental Health Services
  • 4.1.2. Restraints
    • 4.1.2.1. Privacy and Data Security Concerns
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Technology

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 6.1.2. Market Attractiveness Index, By Technology
• 6.2. Natural Language Processing (NLP)*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Machine Learning (ML)
• 6.4. Others

7. By Component

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 7.1.2. Market Attractiveness Index, By Component
• 7.2. Software*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Services

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Symptom Assessment*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Therapeutic Support
• 8.4. Crisis Management
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Woebot Health *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Wysa Ltd
• 11.3. Youper Inc.
• 11.4. X2ai Inc.
• 11.5. Quartet Health
• 11.6. Headspace Health
• 11.7. Marigold Health
• 11.8. BioBeats
• 11.9. Lyra Health, Inc.
• 11.10. Limbic (LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us